Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Fuchs

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Ugeskrift for Laeger|October 10, 1994
[Risk of cataract surgery in patients with myopia. A prospective Danish multicenter study with special reference to a complication]K R Nissen, H J Fuchs, E Goldschmidt, et al.
The New England Journal of Medicine|September 8, 1994
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study GroupH J Fuchs, D S Borowitz, D H Christiansen, et al.
The European Respiratory Journal|June 1, 1995
Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatmentP I Shah, A Bush, G J Canny, et al.
The Journal of Pediatrics|July 1, 1997
Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosisJ D Eisenberg, M L Aitken, H L Dorkin, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 1996
Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbationsR W Wilmott, R S Amin, A A Colin, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Ugeskrift for Laeger|October 10, 1994
[Risk of cataract surgery in patients with myopia. A prospective Danish multicenter study with special reference to a complication]K R Nissen, H J Fuchs, E Goldschmidt, et al.
The New England Journal of Medicine|September 8, 1994
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study GroupH J Fuchs, D S Borowitz, D H Christiansen, et al.
The European Respiratory Journal|June 1, 1995
Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatmentP I Shah, A Bush, G J Canny, et al.
The Journal of Pediatrics|July 1, 1997
Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosisJ D Eisenberg, M L Aitken, H L Dorkin, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 1996
Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbationsR W Wilmott, R S Amin, A A Colin, et al.
Pageof 4